rs4648049

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003998.4(NFKB1):​c.1210+12C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0467 in 1,603,918 control chromosomes in the GnomAD database, including 2,046 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.065 ( 406 hom., cov: 32)
Exomes 𝑓: 0.045 ( 1640 hom. )

Consequence

NFKB1
NM_003998.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.05

Publications

6 publications found
Variant links:
Genes affected
NFKB1 (HGNC:7794): (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]
NFKB1 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 12
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 4-102593580-C-T is Benign according to our data. Variant chr4-102593580-C-T is described in ClinVar as Benign. ClinVar VariationId is 1168687.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.116 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NFKB1NM_003998.4 linkc.1210+12C>T intron_variant Intron 12 of 23 ENST00000226574.9 NP_003989.2 P19838-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NFKB1ENST00000226574.9 linkc.1210+12C>T intron_variant Intron 12 of 23 1 NM_003998.4 ENSP00000226574.4 P19838-2
NFKB1ENST00000505458.5 linkc.1207+12C>T intron_variant Intron 12 of 23 1 ENSP00000424790.1 P19838-1

Frequencies

GnomAD3 genomes
AF:
0.0651
AC:
9902
AN:
152052
Hom.:
401
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.119
Gnomad AMI
AF:
0.0702
Gnomad AMR
AF:
0.0373
Gnomad ASJ
AF:
0.0118
Gnomad EAS
AF:
0.0504
Gnomad SAS
AF:
0.0340
Gnomad FIN
AF:
0.0654
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0453
Gnomad OTH
AF:
0.0518
GnomAD2 exomes
AF:
0.0462
AC:
11217
AN:
243016
AF XY:
0.0447
show subpopulations
Gnomad AFR exome
AF:
0.115
Gnomad AMR exome
AF:
0.0198
Gnomad ASJ exome
AF:
0.0119
Gnomad EAS exome
AF:
0.0630
Gnomad FIN exome
AF:
0.0619
Gnomad NFE exome
AF:
0.0462
Gnomad OTH exome
AF:
0.0413
GnomAD4 exome
AF:
0.0448
AC:
65026
AN:
1451748
Hom.:
1640
Cov.:
34
AF XY:
0.0443
AC XY:
31985
AN XY:
722378
show subpopulations
African (AFR)
AF:
0.123
AC:
3999
AN:
32628
American (AMR)
AF:
0.0212
AC:
908
AN:
42892
Ashkenazi Jewish (ASJ)
AF:
0.0114
AC:
293
AN:
25720
East Asian (EAS)
AF:
0.0517
AC:
2045
AN:
39536
South Asian (SAS)
AF:
0.0280
AC:
2374
AN:
84872
European-Finnish (FIN)
AF:
0.0618
AC:
3286
AN:
53164
Middle Eastern (MID)
AF:
0.0258
AC:
146
AN:
5660
European-Non Finnish (NFE)
AF:
0.0444
AC:
49222
AN:
1107452
Other (OTH)
AF:
0.0460
AC:
2753
AN:
59824
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
2630
5260
7891
10521
13151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1864
3728
5592
7456
9320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0653
AC:
9940
AN:
152170
Hom.:
406
Cov.:
32
AF XY:
0.0657
AC XY:
4887
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.119
AC:
4948
AN:
41496
American (AMR)
AF:
0.0372
AC:
569
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0118
AC:
41
AN:
3472
East Asian (EAS)
AF:
0.0500
AC:
259
AN:
5184
South Asian (SAS)
AF:
0.0346
AC:
167
AN:
4824
European-Finnish (FIN)
AF:
0.0654
AC:
692
AN:
10586
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0453
AC:
3083
AN:
68010
Other (OTH)
AF:
0.0513
AC:
108
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
463
925
1388
1850
2313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0499
Hom.:
43
Bravo
AF:
0.0667
Asia WGS
AF:
0.0540
AC:
186
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.054
DANN
Benign
0.40
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4648049; hg19: chr4-103514737; COSMIC: COSV56956042; COSMIC: COSV56956042; API